سعر تاف ديو 40مكجم 5مجم/مل قطرة للعين 2.5مل 2022

Ophthalmic solution containing travoprost 40 micrograms/ml and timolol 5 mg/ml, 2.5 ml bottle (antiglaucoma).

• Adults: decrease of intraocular pressure in open-angle glaucoma or ocular hypertension insufficiently responsive to topical beta blockers or prostaglandin analogues.Population: Adultselectronic medicines compendium (emc), UK

• Very common: ocular hyperaemia. Common: punctate keratitis, eye pain, visual disturbance, blurred vision, dry eye, eye pruritus, ocular discomfort, eye irritation.International label, same formulation · electronic medicines compendium (emc), UK

• Hypersensitivity to the active substances, excipients or other beta blockers; reactive airway disease including asthma or history of asthma, severe COPD; sinus bradycardia, sick sinus syndrome, sino-atrial block, second/third-degree AV block not controlled with pacemaker; overt cardiac failure, cardiogenic shock; severe allergic rhinitis and corneal dystrophies.International label, same formulation · electronic medicines compendium (emc), UK

• Travoprost and timolol are absorbed systemically; beta-blocker cardiovascular and respiratory adverse reactions seen with systemic beta blockers may occur.International label, same formulation · electronic medicines compendium (emc), UK

• Travoprost has harmful pharmacological effects on pregnancy and/or the foetus/newborn; must not be used in women of child-bearing potential unless adequate contraception is in place; timolol should not be used in pregnancy unless clearly necessary.International label, same formulation · electronic medicines compendium (emc), UK
• Use by breast-feeding women is not recommended; timolol is excreted in breast milk.International label, same formulation · electronic medicines compendium (emc), UK

• Travoprost: Increases uveoscleral outflow of aqueous humour, lowering intraocular pressure (DuoTrav SmPC 5.1).
• Timolol: Reduces aqueous humour formation, lowering intraocular pressure (DuoTrav SmPC 5.1).